However, patients with familial hypobetalipoproteinemia (FHBL) were previously found pathogenic mutations in APOB, which is associated with low-density lipoprotein cholesterol and reducing plasma levels of total cholesterol73. This evidence concerns the gene APOB and familial hypobetalipoproteinemia 1.